APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Animal Softgel Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-Animal Softgel Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025194 pages

Choose your research edition.

Industry ResearchNon-Animal Softgel Capsules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Animal Softgel Capsules Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Non-Animal Softgel Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Animal Softgel Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Animal Softgel Capsules Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non-Animal Softgel Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-Animal Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Animal Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Animal Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-Animal Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Animal Softgel Capsules include Sirio, Erkang, Baihe, Aland, Sunsho Pharmaceutical, Robinson Pharma, Procaps Laboratorios, Fuji Capsule and EuroCaps, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-Animal Softgel Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Animal Softgel Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Animal Softgel Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-Animal Softgel Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Animal Softgel Capsules Segment by Company

Sirio

Erkang

Baihe

Aland

Sunsho Pharmaceutical

Robinson Pharma

Procaps Laboratorios

Fuji Capsule

EuroCaps

Catalent

Captek

Bahrain Pharma

Aenova

Non-Animal Softgel Capsules Segment by Type

Starch Softgel

Gellan Gum Softgel

Carrageenan Softgel

Non-Animal Softgel Capsules Segment by Application

Health Supplements

Pharmaceutical

Others

Non-Animal Softgel Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Animal Softgel Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Animal Softgel Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Animal Softgel Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-Animal Softgel Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Animal Softgel Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-Animal Softgel Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-Animal Softgel Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-Animal Softgel Capsules Industry Trends Table 2. Non-Animal Softgel Capsules Industry Drivers Table 3. Non-Animal Softgel Capsules Industry Opportunities and Challenges Table 4. Non-Animal Softgel Capsules Industry Restraints Table 5. Global Non-Animal Softgel Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-Animal Softgel Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-Animal Softgel Capsules Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Non-Animal Softgel Capsules Sales Market Share by Manufacturers Table 9. Global Non-Animal Softgel Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Non-Animal Softgel Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-Animal Softgel Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-Animal Softgel Capsules Manufacturers, Product Type & Application Table 13. Global Non-Animal Softgel Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-Animal Softgel Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Starch Softgel Table 17. Major Manufacturers of Gellan Gum Softgel Table 18. Major Manufacturers of Carrageenan Softgel Table 19. Global Non-Animal Softgel Capsules Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Non-Animal Softgel Capsules Sales by Type (2021-2026) & (M Units) Table 21. Global Non-Animal Softgel Capsules Sales by Type (2027-2032) & (M Units) Table 22. Global Non-Animal Softgel Capsules Sales Market Share by Type (2021-2026) Table 23. Global Non-Animal Softgel Capsules Sales Market Share by Type (2027-2032) Table 24. Global Non-Animal Softgel Capsules Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 25. Global Non-Animal Softgel Capsules Revenue by Type (2021-2026) & (M Units) Table 26. Global Non-Animal Softgel Capsules Revenue by Type (2027-2032) & (M Units) Table 27. Global Non-Animal Softgel Capsules Revenue Market Share by Type (2021-2026) Table 28. Global Non-Animal Softgel Capsules Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Health Supplements Table 30. Major Manufacturers of Pharmaceutical Table 31. Major Manufacturers of Others Table 32. Global Non-Animal Softgel Capsules Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 33. Global Non-Animal Softgel Capsules Sales by Application (2021-2026) & (M Units) Table 34. Global Non-Animal Softgel Capsules Sales by Application (2027-2032) & (M Units) Table 35. Global Non-Animal Softgel Capsules Sales Market Share by Application (2021-2026) Table 36. Global Non-Animal Softgel Capsules Sales Market Share by Application (2027-2032) Table 37. Global Non-Animal Softgel Capsules Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 38. Global Non-Animal Softgel Capsules Revenue by Application (2021-2026) & (M Units) Table 39. Global Non-Animal Softgel Capsules Revenue by Application (2027-2032) & (M Units) Table 40. Global Non-Animal Softgel Capsules Revenue Market Share by Application (2021-2026) Table 41. Global Non-Animal Softgel Capsules Revenue Market Share by Application (2027-2032) Table 42. Global Non-Animal Softgel Capsules Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 43. Global Non-Animal Softgel Capsules Sales by Region (2021-2026) & (M Units) Table 44. Global Non-Animal Softgel Capsules Sales Market Share by Region (2021-2026) Table 45. Global Non-Animal Softgel Capsules Sales Forecasted by Region (2027-2032) & (M Units) Table 46. Global Non-Animal Softgel Capsules Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Non-Animal Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 48. North America Non-Animal Softgel Capsules Sales by Country (2021-2026) & (M Units) Table 49. North America Non-Animal Softgel Capsules Sales by Country (2027-2032) & (M Units) Table 50. Europe Non-Animal Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 51. Europe Non-Animal Softgel Capsules Sales by Country (2021-2026) & (M Units) Table 52. Europe Non-Animal Softgel Capsules Sales by Country (2027-2032) & (M Units) Table 53. Asia Pacific Non-Animal Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 54. Asia Pacific Non-Animal Softgel Capsules Sales by Country (2021-2026) & (M Units) Table 55. Asia Pacific Non-Animal Softgel Capsules Sales by Country (2027-2032) & (M Units) Table 56. South America, Middle East and Africa Non-Animal Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 57. South America, Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2021-2026) & (M Units) Table 58. South America, Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2027-2032) & (M Units) Table 59. Global Non-Animal Softgel Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Non-Animal Softgel Capsules Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Non-Animal Softgel Capsules Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Non-Animal Softgel Capsules Revenue Market Share by Region (2021-2026) Table 63. Global Non-Animal Softgel Capsules Revenue Market Share by Region (2027-2032) Table 64. Sirio Company Information Table 65. Sirio Business Overview Table 66. Sirio Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sirio Non-Animal Softgel Capsules Product Portfolio Table 68. Sirio Recent Development Table 69. Erkang Company Information Table 70. Erkang Business Overview Table 71. Erkang Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Erkang Non-Animal Softgel Capsules Product Portfolio Table 73. Erkang Recent Development Table 74. Baihe Company Information Table 75. Baihe Business Overview Table 76. Baihe Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Baihe Non-Animal Softgel Capsules Product Portfolio Table 78. Baihe Recent Development Table 79. Aland Company Information Table 80. Aland Business Overview Table 81. Aland Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Aland Non-Animal Softgel Capsules Product Portfolio Table 83. Aland Recent Development Table 84. Sunsho Pharmaceutical Company Information Table 85. Sunsho Pharmaceutical Business Overview Table 86. Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio Table 88. Sunsho Pharmaceutical Recent Development Table 89. Robinson Pharma Company Information Table 90. Robinson Pharma Business Overview Table 91. Robinson Pharma Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Robinson Pharma Non-Animal Softgel Capsules Product Portfolio Table 93. Robinson Pharma Recent Development Table 94. Procaps Laboratorios Company Information Table 95. Procaps Laboratorios Business Overview Table 96. Procaps Laboratorios Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio Table 98. Procaps Laboratorios Recent Development Table 99. Fuji Capsule Company Information Table 100. Fuji Capsule Business Overview Table 101. Fuji Capsule Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Fuji Capsule Non-Animal Softgel Capsules Product Portfolio Table 103. Fuji Capsule Recent Development Table 104. EuroCaps Company Information Table 105. EuroCaps Business Overview Table 106. EuroCaps Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. EuroCaps Non-Animal Softgel Capsules Product Portfolio Table 108. EuroCaps Recent Development Table 109. Catalent Company Information Table 110. Catalent Business Overview Table 111. Catalent Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Catalent Non-Animal Softgel Capsules Product Portfolio Table 113. Catalent Recent Development Table 114. Captek Company Information Table 115. Captek Business Overview Table 116. Captek Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Captek Non-Animal Softgel Capsules Product Portfolio Table 118. Captek Recent Development Table 119. Bahrain Pharma Company Information Table 120. Bahrain Pharma Business Overview Table 121. Bahrain Pharma Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio Table 123. Bahrain Pharma Recent Development Table 124. Aenova Company Information Table 125. Aenova Business Overview Table 126. Aenova Non-Animal Softgel Capsules Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Aenova Non-Animal Softgel Capsules Product Portfolio Table 128. Aenova Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Non-Animal Softgel Capsules Distributors List Table 132. Non-Animal Softgel Capsules Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Non-Animal Softgel Capsules Product Image Figure 2. Global Non-Animal Softgel Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Animal Softgel Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Animal Softgel Capsules Sales (2021-2032) & (M Units) Figure 5. Global Non-Animal Softgel Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-Animal Softgel Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Starch Softgel Image Figure 9. Gellan Gum Softgel Image Figure 10. Carrageenan Softgel Image Figure 11. Global Non-Animal Softgel Capsules Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Non-Animal Softgel Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Non-Animal Softgel Capsules Sales Market Share by Type (2021-2032) Figure 14. Global Non-Animal Softgel Capsules Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 15. Global Non-Animal Softgel Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Non-Animal Softgel Capsules Revenue Market Share by Type (2021-2032) Figure 17. Health Supplements Image Figure 18. Pharmaceutical Image Figure 19. Others Image Figure 20. Global Non-Animal Softgel Capsules Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Non-Animal Softgel Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Non-Animal Softgel Capsules Sales Market Share by Application (2021-2032) Figure 23. Global Non-Animal Softgel Capsules Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 24. Global Non-Animal Softgel Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Non-Animal Softgel Capsules Revenue Market Share by Application (2021-2032) Figure 26. North America Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 27. North America Non-Animal Softgel Capsules Sales Market Share by Country (2021-2032) Figure 28. U.S. Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Canada Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Mexico Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Europe Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 32. Europe Non-Animal Softgel Capsules Sales Market Share by Country (2021-2032) Figure 33. Germany Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 34. France Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 35. U.K. Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Italy Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Netherlands Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Asia Pacific Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Asia Pacific Non-Animal Softgel Capsules Sales Market Share by Country (2021-2032) Figure 40. China Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Japan Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 42. South Korea Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Southeast Asia Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 44. India Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 45. Australia Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 46. South America, Middle East and Africa Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South America, Middle East and Africa Non-Animal Softgel Capsules Sales Market Share by Country (2021-2032) Figure 48. Brazil Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 49. South Africa Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Saudi Arabia Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Turkey Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Argentina Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 53. UAE Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Egypt Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Chile Non-Animal Softgel Capsules Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Global Non-Animal Softgel Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Non-Animal Softgel Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Non-Animal Softgel Capsules Revenue (2021-2032) & (US$ Million) Figure 59. North America Non-Animal Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Non-Animal Softgel Capsules Revenue (2021-2032) & (US$ Million) Figure 61. Europe Non-Animal Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Non-Animal Softgel Capsules Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Non-Animal Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Non-Animal Softgel Capsules Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Non-Animal Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Non-Animal Softgel Capsules Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Non-Animal Softgel Capsules Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Starch Softgel
  • Gellan Gum Softgel
  • Carrageenan Softgel
Applications
  • Health Supplements
  • Pharmaceutical
  • Others
Companies covered
  • Sirio
  • Erkang
  • Baihe
  • Aland
  • Sunsho Pharmaceutical
  • Robinson Pharma
  • Procaps Laboratorios
  • Fuji Capsule
  • EuroCaps
  • Catalent
  • Captek
  • Bahrain Pharma
  • Aenova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-Animal Softgel Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-Animal Softgel Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-Animal Softgel Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-Animal Softgel Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-Animal Softgel Capsules Market Dynamics
  1. 2.1 Non-Animal Softgel Capsules Industry Trends
  2. 2.2 Non-Animal Softgel Capsules Industry Drivers
  3. 2.3 Non-Animal Softgel Capsules Industry Opportunities and Challenges
  4. 2.4 Non-Animal Softgel Capsules Industry Restraints
3 Non-Animal Softgel Capsules Market by Manufacturers
  1. 3.1 Global Non-Animal Softgel Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-Animal Softgel Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-Animal Softgel Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-Animal Softgel Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-Animal Softgel Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-Animal Softgel Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Non-Animal Softgel Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-Animal Softgel Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-Animal Softgel Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-Animal Softgel Capsules Tier 1, Tier 2, and Tier 3
4 Non-Animal Softgel Capsules Market by Type
  1. 4.1 Non-Animal Softgel Capsules Type Introduction
  2. 4.1.1 Starch Softgel
  3. 4.1.2 Gellan Gum Softgel
  4. 4.1.3 Carrageenan Softgel
  5. 4.2 Global Non-Animal Softgel Capsules Sales by Type
  6. 4.2.1 Global Non-Animal Softgel Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Non-Animal Softgel Capsules Sales by Type (2021-2032)
  8. 4.2.3 Global Non-Animal Softgel Capsules Sales Market Share by Type (2021-2032)
  9. 4.3 Global Non-Animal Softgel Capsules Revenue by Type
  10. 4.3.1 Global Non-Animal Softgel Capsules Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Non-Animal Softgel Capsules Revenue by Type (2021-2032)
  12. 4.3.3 Global Non-Animal Softgel Capsules Revenue Market Share by Type (2021-2032)
5 Non-Animal Softgel Capsules Market by Application
  1. 5.1 Non-Animal Softgel Capsules Application Introduction
  2. 5.1.1 Health Supplements
  3. 5.1.2 Pharmaceutical
  4. 5.1.3 Others
  5. 5.2 Global Non-Animal Softgel Capsules Sales by Application
  6. 5.2.1 Global Non-Animal Softgel Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-Animal Softgel Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Non-Animal Softgel Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Non-Animal Softgel Capsules Revenue by Application
  10. 5.3.1 Global Non-Animal Softgel Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-Animal Softgel Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Non-Animal Softgel Capsules Revenue Market Share by Application (2021-2032)
6 Global Non-Animal Softgel Capsules Sales by Region
  1. 6.1 Global Non-Animal Softgel Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Animal Softgel Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Non-Animal Softgel Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Non-Animal Softgel Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-Animal Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-Animal Softgel Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-Animal Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-Animal Softgel Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-Animal Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-Animal Softgel Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-Animal Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-Animal Softgel Capsules Revenue by Region
  1. 7.1 Global Non-Animal Softgel Capsules Revenue by Region
  2. 7.1.1 Global Non-Animal Softgel Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-Animal Softgel Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-Animal Softgel Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-Animal Softgel Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-Animal Softgel Capsules Revenue (2021-2032)
  8. 7.2.2 North America Non-Animal Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-Animal Softgel Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Non-Animal Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-Animal Softgel Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-Animal Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-Animal Softgel Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-Animal Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sirio
  2. 8.1.1 Sirio Company Information
  3. 8.1.2 Sirio Business Overview
  4. 8.1.3 Sirio Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sirio Non-Animal Softgel Capsules Product Portfolio
  6. 8.1.5 Sirio Recent Developments
  7. 8.2 Erkang
  8. 8.2.1 Erkang Company Information
  9. 8.2.2 Erkang Business Overview
  10. 8.2.3 Erkang Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Erkang Non-Animal Softgel Capsules Product Portfolio
  12. 8.2.5 Erkang Recent Developments
  13. 8.3 Baihe
  14. 8.3.1 Baihe Company Information
  15. 8.3.2 Baihe Business Overview
  16. 8.3.3 Baihe Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baihe Non-Animal Softgel Capsules Product Portfolio
  18. 8.3.5 Baihe Recent Developments
  19. 8.4 Aland
  20. 8.4.1 Aland Company Information
  21. 8.4.2 Aland Business Overview
  22. 8.4.3 Aland Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Aland Non-Animal Softgel Capsules Product Portfolio
  24. 8.4.5 Aland Recent Developments
  25. 8.5 Sunsho Pharmaceutical
  26. 8.5.1 Sunsho Pharmaceutical Company Information
  27. 8.5.2 Sunsho Pharmaceutical Business Overview
  28. 8.5.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio
  30. 8.5.5 Sunsho Pharmaceutical Recent Developments
  31. 8.6 Robinson Pharma
  32. 8.6.1 Robinson Pharma Company Information
  33. 8.6.2 Robinson Pharma Business Overview
  34. 8.6.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Robinson Pharma Non-Animal Softgel Capsules Product Portfolio
  36. 8.6.5 Robinson Pharma Recent Developments
  37. 8.7 Procaps Laboratorios
  38. 8.7.1 Procaps Laboratorios Company Information
  39. 8.7.2 Procaps Laboratorios Business Overview
  40. 8.7.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio
  42. 8.7.5 Procaps Laboratorios Recent Developments
  43. 8.8 Fuji Capsule
  44. 8.8.1 Fuji Capsule Company Information
  45. 8.8.2 Fuji Capsule Business Overview
  46. 8.8.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fuji Capsule Non-Animal Softgel Capsules Product Portfolio
  48. 8.8.5 Fuji Capsule Recent Developments
  49. 8.9 EuroCaps
  50. 8.9.1 EuroCaps Company Information
  51. 8.9.2 EuroCaps Business Overview
  52. 8.9.3 EuroCaps Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EuroCaps Non-Animal Softgel Capsules Product Portfolio
  54. 8.9.5 EuroCaps Recent Developments
  55. 8.10 Catalent
  56. 8.10.1 Catalent Company Information
  57. 8.10.2 Catalent Business Overview
  58. 8.10.3 Catalent Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Catalent Non-Animal Softgel Capsules Product Portfolio
  60. 8.10.5 Catalent Recent Developments
  61. 8.11 Captek
  62. 8.11.1 Captek Company Information
  63. 8.11.2 Captek Business Overview
  64. 8.11.3 Captek Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Captek Non-Animal Softgel Capsules Product Portfolio
  66. 8.11.5 Captek Recent Developments
  67. 8.12 Bahrain Pharma
  68. 8.12.1 Bahrain Pharma Company Information
  69. 8.12.2 Bahrain Pharma Business Overview
  70. 8.12.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio
  72. 8.12.5 Bahrain Pharma Recent Developments
  73. 8.13 Aenova
  74. 8.13.1 Aenova Company Information
  75. 8.13.2 Aenova Business Overview
  76. 8.13.3 Aenova Non-Animal Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Aenova Non-Animal Softgel Capsules Product Portfolio
  78. 8.13.5 Aenova Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-Animal Softgel Capsules Value Chain Analysis
  2. 9.1.1 Non-Animal Softgel Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-Animal Softgel Capsules Production Mode & Process
  6. 9.2 Non-Animal Softgel Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-Animal Softgel Capsules Distributors
  9. 9.2.3 Non-Animal Softgel Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst